top cx logo
cx logo
Explorearrow down
search icon

First transplant in America using French-invented artificial heart

Clinical trial of medical device known as Aeson, made by French company Carmat, is currently underway in the US with first transplant complete and more in the pipeline

The Carmat heart is now undergoing clinical trial in America (stock image) Pic: totojang1977 / Shutterstock

The first transplant using an artificial heart produced by French biomedical company Carmat has taken place in US, it was confirmed on July 15. 

The procedure was carried out at Duke University Hospital in Durham (North Carolina), one of the largest American centres for cardiology.

"This clinical study will help us determine whether the device’s properties are beneficial to patients who currently have very few options" said Dr Carmelo A. Milano, one of the heart surgeons involved, who was quoted in Carmat’s press release.

There are plans for 10 patients to be involved in this latest clinical study in total, in order to fulfil the requirements of the US' Food and Drug Administration.

Three other cardiology centres have therefore received training in preparation and are now in the process of selecting patients to join the study.

This first clinical trial in America will be "vital for our expansion into the world’s largest market for medical devices" said Stéphane Piat, Chief Executive Officer at Carmat.

Progress reports on the first three transplant patients will be compiled after 60 days, before the next seven patients are recruited, Carmat said.

Clinical trials in France

The first Carmat heart transplant in France was completed back in December 2013. Testing was paused after France’s first artificial heart transplant patient died in 2014, but soon resumed.

Issues with the device that contributed to the eventual deaths of the first two patients were revealed as electronic component failures that have since been corrected, Le Point reported.

Carmat heart now CE marked medical device

Known as the ‘Aeson’, the world’s most advanced total artificial heart was invented by the French heart surgeon Alain Carpentier.

European CE certification was obtained in December 2020, meaning it can now be marketed in countries that require this marking.

France and Germany are expected to be among the first to adopt them.

Related stories

Artificial hearts to be available in France by 2023
First artificial heart transplant done outside France

Resident or second-home owner in France?
Benefit from our daily digest of headlines and how-to's to help you make the most of life in France
By joining the newsletter, you agree to our Terms & Conditions and Privacy Policy
See more popular articles
The Connexion Help Guides
featured helpguide
Healthcare in France*
Featured Help Guide
- Understand the French healthcare system, how you access it and how you are reimbursed - Useful if you are new to the French healthcare system or want a more in-depth understanding - Reader question and answer section Aimed at non-French nationals living here, the guide gives an overview of what you are (and are not) covered for. There is also information for second-home owners and regular visitors.
Get news, views and information from France
You have 2 free subscriber articles left
Subscribe now to read unlimited articles and exclusive content
Already a subscriber? Log in now